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MembraneThe HIV fusion peptide (HFP) is a biologically relevant model system to understand virus/host cell fusion. 2H
and 31P NMR spectroscopies were applied to probe the structure and motion of membranes with bound HFP
and with a lipid headgroup and cholesterol composition comparable to that of membranes of host cells of
HIV. The lamellar phase was retained for a variety of highly fusogenic HFP constructs as well as a non-
fusogenic HFP construct and for the inﬂuenza virus fusion peptide. The lamellar phase is therefore a
reasonable structure for modeling the location of HFP in lipid/cholesterol dispersions. Relative to no HFP,
membrane dispersions with HFP had faster 31P transverse relaxation and faster transverse relaxation of acyl
chain 2H nuclei closest to the lipid headgroups. Relative to no HFP, mechanically aligned membrane samples
with HFP had broader 31P signals with a larger fraction of unoriented membrane. The relaxation and aligned
sample data are consistent with bilayer curvature induced by the HFP which may be related to its fusion
catalytic function. In some contrast to the subtle effects of HFP on a host-cell-like membrane composition, an
isotropic phase was observed in dispersions rich in phosphatidylethanolamine lipids and with bound HFP.
© 2009 Elsevier B.V. All rights reserved.1. Introduction
Membrane fusion plays an essential role in enveloped virus entry
into target host cells [1]. For the human immunodeﬁciency virus (HIV),
fusion occurs directly between the viral and target cell membranes
with subsequent formation of a single membrane enclosing the viral
and host cell contents. Membrane fusion is carefully controlled on a
spatial and temporal basis so as to keep the host cell intact for viral
replication. Fusion is aided by interaction between the target cell
membrane and the ∼20-residue N-terminal “fusion peptide” (HFP)
domain of the gp41 viral envelope protein [1,2].
Peptides with the HFP sequence have been shown to induce fusion
between liposomes and between erythrocytes, and numerous muta-
tional studies have shown strong correlations between fusion
peptide-induced liposome fusion and virus/host cell fusion [2].
These data support the study of the HFP/membrane interaction. The
structure of the HFP has been studied by a variety of methods and
there is an experimentally-based high-resolution secondary and
tertiary structure model of the HFP in membranes whose lipid
headgroup and cholesterol composition are comparable to that of host
cells of the virus [3].
Studies have also been carried out on the location of the HFP in the
membrane and on the effect of the HFP on membrane structure and1 517 353 1793.
liky).
ll rights reserved.motion. The Ala-1 to Gly-3 and Ala-14 to Gly-16 regions of the HFP are
in close contact with lipid headgroups while the Ala-6 to Leu-12
region appears to be more deeply inserted into the membrane interior
[4,5]. There are also reports that the HFP or the related simian
immunodeﬁciency virus fusion peptide induces a non-lamellar phase
for lipid compositions rich in phosphatidylethanolamine (PE) [6–8].
This result has been correlated with the observation that HFP and
other viral fusion peptides promote the formation of the inverted
hexagonal phase, which has negative curvature [9,10]. These data may
relate to the fusion mechanisms through the “stalk” intermediates in
which the contacting monolayers have negative curvature [11,12]. The
fusion peptide may promote formation of stalk intermediates by
inducing equilibrium negative curvature [13].
Development of high-resolution structural models for the HFP/
membrane interaction will require better understanding of the
dependence of the lipid and cholesterol phase on HFP construct as
well as lipid and cholesterol composition. In this paper, 2H and 31P
nuclear magnetic resonance (NMR) spectroscopies were applied to
study the structure and motion of membranes with bound HFP. 2H
NMR spectra are dominated by the quadrupole interaction with the
local electric ﬁeld gradient. In unaligned samples, each 2H produces a
powder pattern with two distinct peaks whose frequency separation
provides information on segmental motion [14,15]. Measurement of
the longitudinal (T1) and transverse (T2) spin relaxation times
provides information on the motions of phospholipid molecules
[14,16]. The longitudinal relaxation rate is sensitive to fast motions
having correlation times τ1≤ω0−1 (where ω0 is the nuclear Larmor
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formations and rotations of the molecules around the bilayer normal
whereas the transverse relaxation rate is also sensitive to slow
motions with correlation times τ2≫ ω0−1 [14,17]. The slow motions
that contribute to transverse relaxation can be interpreted to be from
molecular diffusion along curved membrane surfaces [17].
2. Materials and methods
2.1. Materials
Rink amide resinwas purchased fromAdvanced Chemtech (Louisville,
KY), and9-ﬂuorenylmethoxycarbonyl (FMOC)-aminoacidswereobtained
from Peptides International (Louisville, KY). Labeled amino acids were
purchased from Icon Services Inc. (Summit, NJ) or from Cambridge
Isotopes (Andover, MA) and the FMOC group was added using literature
methods [18,19]. 1,2-Dimyristoyl(d54)-sn-glycero-3-phosphocholine
(DMPCdac), 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC),
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoethanolamine (POPE), 1-pal-
mitoyl-2-oleoyl-sn-glycero-3-[phospho-L-serine] (POPS), phosphatidyli-
nositol (PI), sphingomyelin, N-(7-nitro-2,1,3-benzoxadiazol-4-yl)-
phosphatidylethanolamine (N-NBD-PE), N-(lissamine Rhodamine B
sulfonyl)-phosphatidylethanolamine (N-Rh-PE), 1,2-dioleoyl-sn-gly-
cero-3-phosphocholine (DOPC), 1,2-dioleoyl-sn-glycero-3-phospho-
ethanoloamine (DOPE), 1,2-O-ditetradecyl- sn-glycero-3-
phosphocholine (DTPC), 1,2-O-ditetradecyl-sn-glycero-3-[phospho-rac-
(1-glycerol)] (DTPG), 1-palmitoyl-2-(5-ﬂuoropalmitoyl)-sn-glycero-3-
phosphocholine (DPPC-F(C5)), and cholesterol were purchased from
Avanti Polar Lipids (Alabaster, AL). The BCA protein assay was
obtained from Pierce (Rockford, IL). N-2-hydroxyethylpiperazine-N′-
2-ethanesulfonic acid (HEPES) and Triton X-100 were obtained from
Sigma (St. Louis, MO).
2.2. Peptides
HFP contained the 23 N-terminal residues of HIV gp41
(AVGIGALFLGFLGAAGSTMGARS) and was synthesized as a C-terminal
amide using a peptide synthesizer (ABI 431A, Foster City, CA)
equipped for FMOC chemistry. HFP_K3with sequence AVGIGALFLGFL-
GAAGSTMGARSKKK contained three non-native C-terminal lysines
which improved aqueous solubility. HFP_K5 had sequence AVGI-
GALFLGFLGAAGSTMGARSWKKKKKA and HFPmut_K5 had sequence
AEGIGALFLGFLGAAGSTMGARSWKKKKKA with the V2E mutation and
is a non-fusogenic mutant in HIV and as a peptide [20,21]. HFPtr_K5
contained three HFP_K5 strands that were chemically cross-linked at
their C-termini to form a HFP trimer which is the putative oligomeric
state of gp41 [5]. The inﬂuenza virus fusion peptide (IFP_K4) had
sequence GLFGAIAGFIENGWEGMIDGGGKKKKG where the seven C-
terminal residues are a solubility tag [22]. Melittin with sequence
GIGAVLKVLTTGLPALISWIKRKRQQ is the major component of bee
venom and served as a model lytic peptide [23,24].
2.3. Membrane preparation
Samples were usually prepared with a lipid/cholesterol mixture
that reﬂects the approximate lipid and cholesterol content of the host
cells of HIV [25,26]. One mixture, denoted “LM3,” had POPC, POPE,
POPS, sphingomyelin, PI, and cholesterol in a 10:5:2:2:1:10 mol ratio.
Another mixture, denoted “LM3-DMPCdac” had DMPCdac, POPE,
POPS, sphingomyelin, PI, and cholesterol in a 10:5:2:2:1:10 mol ratio.
The DMPCdac was perdeuterated along the acyl sidechains. Some of
the samples were prepared with DTPC:DTPG:DPPC-F(C5):cholesterol
in a 8:2:1:5 mol ratio. This composition also reﬂected the cholesterol
content and large fraction of lipids with choline headgroups in
membranes of host cells of HIV. The DTPG reﬂected negatively charged
lipids in thesemembranes and the DPPC-F(C5) provided 19F which is auseful lipid probe nucleus for future NMR experiments. The DTPC and
DTPG lipids contained ether- rather than ester-linkages which greatly
reduce the lipid natural abundance contribution to the 13CO signal.
This reduction is very useful in measurements of peptide 13CO-lipid
31P and peptide 13CO-lipid 19F distances which provide experimental
constraints on peptide location in the membrane [4,5]. It is noted that
PG is not the anionic lipid found in mammalian cell membranes. Lipid
and cholesterol powders were dissolved together in chloroform. The
chloroform was removed under a stream of nitrogen gas followed by
overnight vacuum pumping. Lipid dispersions were formed by
addition of water or buffer followed by homogenization with
freeze–thaw cycles. In some cases, large unilamellar vesicles (LUVs)
of 100 nm diameter were prepared by extrusion.
2.4. Lipid mixing assay for membrane fusion
Two types of LM3 LUVs were prepared [27]. One set contained
2 mol% of the ﬂuorescent lipid N-NBD-PE and 2 mol% of the
quenching lipid N-Rh-PE while the other set only contained
unlabeled lipids. Fluorescently labeled and unlabeled vesicles
were mixed in a 1:9 ratio. Following addition of peptide, lipid
mixing between labeled and unlabeled vesicles caused dilution of
the labeled lipids with a resulting increase of ﬂuorescence.
Fluorescence was recorded using 4 nm bandwidth on a ﬂuorimeter
operating at excitation and emission wavelengths of 465 nm and
530 nm, respectively (Instruments S.A. Fluoromax-2, Edison, NJ).
Measurements were carried out with continuous stirring at 37 °C
with 2 ml of 150 μM LUVs in 5 mM HEPES at pH 7.0. An aliquot of
aqueous 0.5 mM peptide solution was added to achieve the desired
peptide:lipid mol ratio, and the change in ﬂuorescence of the
sample was monitored following this addition. The initial ﬂuores-
cence intensity F0 referenced zero lipid mixing and the maximum
ﬂuorescence intensity Fmax was obtained following addition of
20 μl of 10% Triton X-100. Percent lipid mixing at time t was given
by [(Ft−F0)/(Fmax−F0)]×100.
2.5. Membrane dispersion sample preparation
Peptide solutions were mixed with aqueous dispersions of lipid
and cholesterol usually in 5 mM HEPES buffer at pH 7.0. The
samples lacked physiologically relevant dissolved salt because salt
causes aggregation of the HFP [28]. In some cases, particularly the
magic angle spinning (MAS) samples, membrane LUVs were initially
prepared and after peptide binding, the LUVs with bound peptide
were centrifuged to form a more concentrated sample. Electron
micrographs have shown that after HFP binding, the ﬁnal mem-
brane morphology is large aggregates of fused vesicles [29]. 2H-
depleted water was used for samples prepared for 2H NMR
spectroscopy.
2.6. Oriented sample preparation
Microscope cover slips were cut to ﬁt inside a glass tubewhich was
either cylindricalwith a 5mmdiameter or cubicwith a 10mm×10mm
cross-section. A 50 μl aliquot of hydrated membrane dispersion or
dispersion plus fusion peptide was placed on each slide. Each aliquot
contained 1.0–1.5 mg of lipid. Over the course of one to two days, bulk
water was allowed to evaporate. The plates were then stacked inside
the glass tube, and the tube was placed inside a bottle containing
saturated (NH4)3PO4 solution. The sealed bottle was placed in an
incubator at 35–40 °C for a few days so that the plates were in vapor
contactwith a 90% humidity environment. The tubewas then removed
from the bottle, and a specially machined Kel-F plug was inserted into
its open end and then sealed with epoxy. In these sealed samples, the
lipids remain hydrated and oriented over the course of at least one
month.
Fig. 1. (a) HFP_K3-induced lipid mixing of LM3 LUVs at 37 °C with HFP_K3, total lipid,
and cholesterol concentrations of 1.5, 150, and 75 μM, respectively. (b, c) REDOR-
ﬁltered magic angle spinning 13C NMR spectra of LM3-associated HFP and HFP_K3,
respectively. The peptides were 13CO labeled at Phe-8 and 15N labeled at Leu-9 and
the S0−S1 spectra were dominated by the Phe-8 13CO signal whose peak chemical
shift was consistent with β strand conformation. The samples contained 0.4 μmol
peptide, 40 μmol total lipid, and 20 μmol cholesterol and were cooled with nitrogen
gas at−50 °C. Each spectrum was the sum of ∼10000 acquisitions and was processed
with 50 Hz line broadening.
196 C.M. Gabrys et al. / Biochimica et Biophysica Acta 1798 (2010) 194–2012.7. REDOR NMR
Rotational-echo double-resonance (REDOR) spectroscopy was
performed on a 9.4 T spectrometer (Varian Inﬁnity Plus, Palo Alto,
CA) using a triple resonance MAS probe equipped with a 6 mm
diameter rotor [30]. The NMR detection channel was tuned to 13C, the
decoupling channel was tuned to 1H, and the third channel was tuned
to 15N. Experiments were carried out using a MAS frequency of
8000±2 Hz. Cross-polarization at 50 kHz for 1.2 mswas followed by a
1 ms REDOR dephasing period and then direct 13C detection. A single
50 kHz 13C refocusing π pulse at 155 ppm was placed at the center of
the dephasing time, and 1H TPPM decoupling at 65 kHz was applied
during both dephasing and detection [31]. For the S1 acquisition, the
dephasing time contained a 40 kHz 15N π pulse at the middle and end
of each rotor period, while the S0 acquisition did not contain these
pulses. XY-8 phase cycling was used for the 15N pulses and the 15N
frequency was near the isotropic peptide amide resonance [32,33].
The recycle delay was 1 s. Chemical shifts were referenced to the
methylene carbon resonance of adamantane at 40.5 ppm [34].
2.8. Static NMR
Experiments were done on a 9.4 T spectrometer (Varian VXR or
Varian Inﬁnity Plus, Palo Alto, CA) using either a Varian single or triple
resonance probe or a home-built double resonance probe. The NMR
detection channel was tuned to 2H or 31P and the decoupling channel
was tuned to 1H. RF ﬁelds of about 40 kHz, 50 kHz, and 40 kHz were
used for 2H, 31P, and 1H, respectively.
For 2H, the quadrupolar echo sequence (π/2)−τ1−(π/2)−τ2
−acquire was used to minimize effects from probe ring-down. The
phase of the ﬁrst π/2 pulse was x and the phase of the second π/2
pulse alternated between y and −y. The recycle delay was 1 s. To
determine the 2H T2, the decay of the acquired signal was measured as
a function of synchronous incrementation of τ1 and τ2. To determine
the 2H T1, a (π)x−d1 inversion-recovery module was inserted before
the echo sequence, and the variation of the acquired signal was
measured as a function of d1.
For 31P experiments, Bloch decay spectra with 1H decoupling were
taken using a recycle delay of 3 or 4 s and CYCLOPS phase cycling [35].
The 31P chemical shifts were referenced to either phosphoric acid at
0.0 ppm, triphenylphosphite at 130.0 ppm, or triphenylphosphate at
−17.6 ppm. The 31P T2 measurements were done using a chemical
shift echo sequence π/2−τ−π−τ−acquire and the total echo
times ranged from 480–1560 μs.
3. Results
3.1. Representative fusogenicity and MAS NMR spectra
HFP, HFP_K3, and HFPtr_K5 all induce signiﬁcant vesicle fusion
and representative lipid mixing data for HFP_K3 are displayed in
Fig. 1a. These results are comparable to those obtained for HFP and
indicate that addition of the three C-terminal lysines does not affect
the fusogenicity of the peptide. HFPtr_K5 induces even more rapid
vesicle fusion [5,36]. In membranes with physiologically relevant
cholesterol content, the 16 N-terminal residues of HFP, HFP_K3,
HFPmut_K5, and HFPtr_K5 adopt predominant β strand conforma-
tion, as primarily evidenced by 13C chemical shifts [3,5,28,36]. Fig.
1b, c displays representative 13C REDOR difference spectra of HFP
and HFP_K3 associated with LM3 membranes. Because of the
speciﬁc isotopic labeling and the REDOR approach, natural abun-
dance signals are ﬁltered out and only the signal from the labeled
Phe-8 carbonyl is detected in each spectrum [37,38]. For both
samples, the spectra are very similar and consist of a single line
centered at 173 ppm which correlated with β strand rather thanwith helical or coil conformation and is similar to the spectrum
observed for LM3-associated HFPtr_K5 [36,39].
3.2. Static NMR spectra
Fig. 2 displays representative NMR spectra of static samples
containing lipid/cholesterol dispersions where panels a–e are 2H
spectra and panels f–i are 31P spectra. The a–h samples were made
with LM3 and the i sample was made with DOPC:DOPE:cholesterol.
Several of the samples were made a second time and the spectra
were reproducible, in particular sample i whose lineshape differs
signiﬁcantly from the other 31P NMR spectra. Samples were also
prepared with and without the LUV step and by simple mixing of
peptide, lipids, and cholesterol and yielded similar spectra indepen-
dent of preparation method. In addition, the 31P NMR spectra of the
a–c samples are similar to those of the f–h spectra, indicating that
the 31P lineshape is approximately independent of DMPC or POPC
Fig. 2. NMR spectra of lipid/cholesterol dispersions with peptides. 2H spectra are displayed in panels a–e and the samples contained LM3-DMPCdac dispersions with peptide and
peptide:total lipid (excluding cholesterol) mol ratios: (a) no peptide; (b) HFP, 0.03; (c) HFP, 0.10; (d) melittin, 0.03; and (e) melittin, 0.10. 31P spectra are displayed in panels f–h and
the samples contained LM3 dispersions with peptide and peptide:lipid mol ratios: (f) no peptide; (g) HFP, 0.02; and (h) HFP_K3, 0.02. A similar 31P spectrum is displayed in panel i
and contained HFP:total lipid=0.02 with the dispersion composed of DOPC:DOPE:cholesterol in a 1:1:1 mol ratio. A typical sample contained ∼30 μmol total lipid and ∼15 μmol
cholesterol. The 2H and 31P spectra were obtained at 35 °C, were respectively processed with 150 or 50 Hz line broadening, and were respectively the sums of 4000 to 6000 scans or
5000 to 20000 scans.
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presence of the K3 solubility tag.
Each 2H spectrum in panels a–e is a superposition of individual
Pake powder patterns of the 2H nuclei along the DMPC acyl chains.
Each methylene position experiences a different amount of motion
and thus has a different quadrupolar splitting. The motion increases
and the quadrupolar splitting decreases from the headgroup to the
tail. As displayed in panels a–c, there were minor changes in the 2H
NMR spectra with addition of HFP. Relative to the pure LM3-DMPCdac
sample, binding of HFP appears to cause some small increases in
quadrupolar splittings in the range of 1–3% and 2–5% for HFP:
lipid=0.03 and 0.1, respectively. This is consistent with less chain
motion in the presence of HFP. In addition, the peaks of the individual
Pake patterns are broader in the presence of HFP, consistent with a
more heterogeneous distribution of lipid motion. Both of these small
changes are consistent with some interference with lipid motion by
the incorporation of HFP into the membrane. Overall, the 2H spectra
support retention of the membrane bilayer phase for LM3 even with
large quantities of HFP.
In some contrast, panel e with melittin:lipid=0.10 shows a
narrow, isotropic 2H feature, which has ∼200 Hz FWHM linewidth
and which is shifted about 300 Hz upﬁeld of the signal of a 2H2O
reference sample. The narrow feature is likely associated withformation of an isotropic, non-lamellar lipid/cholesterol phase.
Overall, panels a–e indicate that the lytic peptide melittin affects the
LM3 dispersion very differently than does HFP.
Consistent with the 2H spectra, the 31P NMR spectra displayed in
panels f–h show relatively minor effects from the addition of HFP.
The spectrum of the pure LM3 sample in panel f is consistent with a
predominant lamellar phase [40]. In addition, there is a clear
splitting at the low ppm edge with peaks at −25.7 and −28.2 ppm
and less apparent splitting at the high ppm edge with shoulders at 7
and 12 ppm. Assuming that the isotropic 31P chemical shift is
approximately the same for all lipids, the most reasonable
explanation for these splittings is that there is a superposition of
two powder patterns with chemical shift anisotropies (CSAs) of 33
and 40 ppm. The spectra g and h of the samples containing HFP or
HFP_K3 are also consistent with a predominant lamellar phase. In
spectrum g, the upﬁeld splitting is apparent as a −28.5 ppm
shoulder on the −26 ppm peak. The splitting is less clear than in
the pure LM3 sample, probably because of broadening of the
individual powder patterns. This effect is similar to the observed
broadening of the 2H features in the presence of HFP and is
consistent with a more heterogeneous distribution of lipid head-
group motions. When spectrum f (sample without HFP) is
processed with 300 Hz line broadening, its lineshape is similar to
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feature at −15 ppm in spectrum g, which may indicate some small
fraction of isotropic lipid/cholesterol phase [40–42]. This feature is
less apparent in spectrum f and is not apparent in spectrum h
which was prepared with HFP_K3.
The 31P spectrum in panel i for the DOPC:DOPE:cholesterol
mixture with HFP correlates with a predominant isotropic rather
than lamellar phase and is consistent with the work of other
investigators and is different than spectra g–h observed for LM3
with HFP or HFP_K3 [8]. In addition, at room temperature the
spectrum for this sample broadened signiﬁcantly, suggesting that
there is a phase transition between 20 °C and 35 °C. In the absence of
HFP, the 31P spectrum for DOPC:DOPE:cholesterol appeared to be a
superposition of lamellar and isotropic phase spectra. Thus, for DOPC:
DOPE:cholesterol, HFP appears to induce signiﬁcantly greater iso-
tropic phase while our 2H and 31P spectra do not support this
conclusion for LM3. The greatest compositional difference between
LM3 and the DOPC:DOPE:cholesterol mixture is the lipid mol fraction
of PE lipid, 0.25 for the former and 0.50 for the latter composition. PE
lipids are widely used for their propensity to transit between lamellar
and non-lamellar phases [43].
Fig. 3 displays additional 31P NMR spectra of samples that
contained lipid/cholesterol dispersions with composition DTPC:
DTPG:DPPC-F(C5):cholesterol in a 8:2:1:5 mol ratio. Fig. 3 spectra
are consistent with retention of the lamellar phase in samples
containing fusogenic HFP_K5, highly fusogenic HFPtr_K5, non-
fusogenic HFPmut_K5, and IFP_K4 at fusogenic pH 5.0 or less
fusogenic pH 7.4. The somewhat different lineshapes of Fig. 2f–h
and Fig. 3 spectra are likely due to differences in lipid compositions. In
Fig. 2f–h, the samples contained LM3 which had ﬁve different lipid
types with individual 31P lineshapes that are likely somewhat
different from one another. In Fig. 3, the composition was simpler
with three different lipid types and ∼75% of the total lipid was DTPC.
3.3. 2H and 31P relaxation times
2H longitudinal and transverse times were determined for
dispersions containing LM3-DMPCdac dispersions and HFP. TheFig. 3. 31P NMR spectra at 35 °C of dispersion samples composed of DTPC:DTPG:DPPC-F(C5):c
(b) HFP_K5, 0.04; (c) HFPmut_K5, 0.04; (d) HFPtr_K5, 0.013; (e) IFP_K4 at pH 5.0, 0.04; (f) IF
was the sum of 300 to 1000 scans.data were intensities of “outer” and “inner” spectral features as
deﬁned in Fig. 4a where the outer feature is mostly due to 2H close
to the headgroups and the inner feature is mostly due to 2H in the
terminal methyl group. The outer feature intensity was measured
relative to the spectral baseline while the inner feature intensity was
measured relative to an approximate baseline atop the non-methyl
2H transitions.
T1 values were determined by ﬁtting the intensities of the
inversion-recovery spectra as a function of the delay d1:
I d1ð Þ = Ii + ΔI × 1− e−d1 =T1
 n o
ð1Þ
where I(d1) is the measured echo intensity and ﬁtting parameters are
the initial echo intensity Ii, the difference ΔI between the equilibrium
and initial echo intensities, and T1.
Fig. 4b displays the outer feature inversion-recovery data for
LM3-DMPCdac dispersions with HFP:lipid=0 or 0.10. The best-ﬁt
relaxation times for these and other data sets are presented in
Table 1. Within our ﬁtting uncertainties, there is no difference
among the outer feature T1 values or among the inner feature T1
values at different HFP concentrations. The relative uncertainties of
the inner feature T1 values are greater than those of the outer
feature values, in part because of the uncertainty in determining
the inner feature baseline.
2H T2 values were determined from measurements of the echo
intensity as a function of the total echo time, 2τ, where τ is the time
from the end of the second π/2 pulse to the echo formation. The data
were ﬁtted with:
ln I 2τð Þ½  = ln I 0ð Þ½ − 2τ = T2 ð2Þ
where I(2τ ) is the measured echo intensity and I(0) and T2 are ﬁtting
parameters. Fig. 4c displays plots of the outer feature data for the three
different samples, and the best-ﬁt T2 values are listed in Table 1. There
appears to be a 10–15% reduction in the outer feature T2 with addition
of HFP and this reduction was also observed for HFP_K3. The inner
feature intensity data are the same within the listed uncertainties for
the three samples.holesterol (8:2:1:5 mol ratio) with peptide and peptide:lipid mol ratios: (a) no peptide;
P_K4 at pH 7.4, 0.04. Each spectrumwas processedwith 100–150 Hz line broadening and
Fig. 4. (a) 2H NMR spectrum of a LM3-DMPCdac dispersion sample showing “inner” and
“outer” peak intensities which respectively correspond to terminal C2H3 and to C2H2
closest to the lipid headgroups. (b) Outer peak intensities vs delay time d1 in the
inversion-recovery pulse sequence. (c) ln(outer peak intensity) vs echo time 2τ in the
quadrupolar echo sequence. The circles, triangles, and crosses respectively correspond to
HFP:lipid=0, 0.03, and 0.10. Panel c also displays best-ﬁt lines for HFP:lipid=0 and 0.10.
Table 1
Best-ﬁt 2H T1 and T2 values of DMPCdac sidechains in LM3-DMPCdac dispersions
at 35 °C.
HFP:lipid Peak feature T1 (ms) T2 (μs)
0 Outer 53 (1) 327 (10)
Inner 340 (10) 794 (53)
0.03 Outer 50 (2) 268 (5)
Inner 320 (60) 794 (84)
0.10 Outer 51 (2) 294 (10)
Inner 310 (60) 709 (50)
Uncertainties are in parentheses.
Table 2
Best-ﬁt 31P T2 values in dispersions at 35 °C.
HFP_K3:lipid Dispersion type T2 (μs)
0 LM3 2019 (98)
0 LM3-DMPCdac 2054 (72)
0.03 LM3 1171 (104)
0.03 LM3-DMPCdac 1459 (143)
Uncertainties are in parentheses.
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sions with HFP_K3:lipid=0 or 0.03. The T2 values were determined
from measurements of the echo intensities and ﬁtting with Eq. (2) as
described for 2H above, and the best-ﬁt T2 values are displayed in
Table 2. T2 is 30–40% lower for the samples that contain HFP_K3.
3.4. NMR spectra of aligned samples
Fig. 5 displays representative 31P NMR spectra of oriented glass
plate samples containing LM3 and HFP_K3:lipid of (a, b) 0 or (c, d)
0.02. In (a, c) the glass plate normal and magnetic ﬁeld were parallel,
and in (b, d) the normal and ﬁeld were perpendicular. In the absence
of HFP_K3, there is a narrow, dominant 31P feature with peak chemicalshift 10.4 ppm for the parallel orientation and −27.7 ppm for the
perpendicular orientation. The observed chemical shifts indicate that
the lipids are in the lamellar phase and that the lamellae are oriented
with their normal approximately parallel to the glass plate normal.
The CSA is ∼38 ppm and lies between the 33 and 40 ppm CSAs of the
powder patterns observed in the dispersion sample in Fig. 2f. In
another aligned sample, the perpendicular spectrum showed two
peaks at−28.1 and−25.9 that likely correspond to the perpendicular
edges of the powder patterns. In Fig. 5a,b, there are additional small
features at 22, 18, and 0 ppm in the (a) parallel orientation and−33,
−31, and−22 ppm in the (b) perpendicular orientation. These likely
representminor populations of oriented lipids whose CSAs are slightly
different from the CSA of the lipids in themain peak. Assuming that all
of the lipids have approximately the same isotropic 31P chemical shift,
−15 ppm, and considering the relative intensities in the parallel and
perpendicular spectra, the most reasonable interpretation of the
minor peaks is that they arise from threeminor lipid populations with
parallel and perpendicular shifts of 22 and −33 ppm (ﬁrst popula-
tion), 18 and −31 ppm (second population), and 0 and −22 ppm
(third population). In addition, the parallel spectrum (a) also has a
small, broad component with an upﬁeld edge near −28 ppm. This
feature is likely part of the powder pattern of unoriented lipid
corresponding to the LM3 dispersion in Fig. 2f. Integration of the
oriented and unoriented features is consistent with a ∼5% population
of unoriented lipid.
In the presence of HFP_K3, Fig. 5c, d, the 31P spectra are
signiﬁcantly broader, and the unoriented component represents
∼20% of the total signal. The dominant oriented peaks fall at 10.6
and −28.4 ppm in the parallel and perpendicular orientations,
respectively, which are close to the values observed in the a,b spectra
of samples without HFP_K3.
4. Discussion
The interaction of the HFP with the host cell membrane is critical
for fusion between the membranes of HIV and its host cell. There have
been signiﬁcant NMR studies delineating the structure of HFP in
membranes whose “LM3” composition reﬂects the lipid headgroup
and cholesterol composition of membranes of host cells of HIV [3,28].
There have also been NMR studies showing that the HFP induces
formation of non-lamellar isotropic phases in lipid mixtures which
have large fractions of PE [8]. Finally, there have been NMR
measurements of distances between 13CO nuclei in HFP and 31P in
phosphatidylcholine (PC)-rich membranes which indicate proximity
Fig. 5. 31P NMR spectra of aligned samples containing LM3 with the glass plate normal
either (a, c) parallel or (b, d) perpendicular to themagnetic ﬁeld. The a, b sample did not
contain peptide and the c, d sample contained HFP_K3 with HFP_K3:lipid mol
ratio=0.02. Spectra were obtained at 35 °C, processed with 25 Hz line broadening, and
represented the sums of 10000 scans.
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headgroups and insertion of the Ala-6 to Leu-12 region into the
membrane interior [4,5]. In order to understand fusion as well as to
properly interpret the HFP structure and membrane location
measurements, it is important to understand the lipid/cholesterol
phasewith bound HFP as well as the dependence of this phase on lipid
and cholesterol composition. One overall result from analysis of the 2H
and 31P static NMR spectra is that at 35 °C, the lamellar phase is
retained in PC-rich membranes even at HFP:lipid=0.10 whereas a
large fraction of isotropic phase is detected in PE-richmembranes. The
former result holds true for a variety of HFP constructs including a
non-fusogenic mutant as well as a highly active cross-linked trimer
and also for the inﬂuenza virus fusion peptide. Membranes of host
cells of HIV are PC-rich so it appears that HFP acts as a catalyst for
membrane fusion but does not change the equilibrium lamellar phase.
This is a biologically reasonable result because an intact host cell
membrane is important for viability and consequent viral replication.
This result also correlates with membrane stabilization by the ﬁnal
folded state of gp41 [44]. To date, studies of the location of HFP in
lipid/cholesterol dispersions have been done with host-cell-like PC-
rich lipid compositions and based on the data of the present study, it
appears reasonable to use lamellar structure for the lipid/cholesterol
phase in these models. The lytic peptide melittin disrupts PC-rich
membranes which highlights the difference in membrane interaction
of a peptide toxin and a peptide fusogen.
HFP does have some subtle effects on PC-rich membranes as
evidenced by: (1) increases in the transverse relaxation rates of 31P in
the lipid headgroups and 2H in acyl chain positions that are closest to
the lipid headgroups; and (2) broadening of 31P signals and an
increase in the unoriented component in mechanically aligned
membranes. These observations are consistent with measurements
on other fusogenic peptides and with broad 15N signals of HFP in
mechanically aligned samples [22,45–47]. One interpretation of thechanges in the NMR spectra and transverse relaxation rates is HFP-
induced curvature in membranes. This curvature would result in a
greater distribution of lipid molecule orientations in mechanically
aligned samples and therefore a broader distribution of 31P chemical
shifts. Relative to a planar membrane, lipid molecule translation along
a curved membrane in a magnetic ﬁeld would result in a greater rate
of change of the local quadrupolar (2H) or shielding (31P) ﬁeld with
consequent increase in the nuclear spin relaxation rate [17]. Increased
equilibrium curvature would also correlate with a decrease in the
activation energy needed to reach highly curved fusion intermediates
and a consequent increase in the fusion rate [1,13].
The HFP-induced curvature interpretation of the NMR results is
consistent with other experimental data. X-ray measurements of
DOPC membranes with and without bound HFP were interpreted in
terms of HFP-induced reduction of the bending modulus of the
membranes which would result in more highly curved membranes
[48]. Differential scanning calorimetry has shown that the 16-residue
N-terminal portion of HFP lowers the transition temperature of PE
membranes from lamellar to inverted hexagonal phase, and this result
was interpreted in terms of HFP-induction of negative membrane
curvature [9]. As observed in earlier studies as well as the present
work, 31P NMR spectra of HFP bound to PE-rich membranes are
consistent with isotropic membrane phases [8]. Such phases have
been interpreted as arising from highly curved lipid structures such as
small vesicles or a cubic phase [24,49]. Thus, the curvature
interpretation of our results is consistent with interpretation of
other experimental data andwith a reasonable general mechanism for
HFP-induced catalysis of membrane fusion. It is noted, however, that
the induction of curvature by the HFP is not a unique or deﬁnitive
interpretation of our data.
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